Gyno-Canesten, Kombi FORTE, 500 mg und 20 g 1%

7680683530013 CH-68353 Unbekannt

Associated product:

GYNO-CANESTEN Combi FORTE caps vag & crème
Gyno-Canesten, Kombi FORTE, 500 mg und 20 g 1%
Gyno-Canesten, Kombi FORTE, 500 mg und 20 g 1%
Gyno-Canesten, Kombi FORTE, 500 mg und 20 g 1%
1 / 3
google

Article details

Package size
1
Selling units
unbekannt
Measure
Kombipackung(en)
Galenic form
Unbekannt
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
26/01/2023
Patient information leaflet
Français
26/01/2023
Patient information leaflet
Italien
26/01/2023
Summary of Product Characteristics
Allemand
26/01/2023
Summary of Product Characteristics
Français
26/01/2023
Summary of Product Characteristics
Italien
26/01/2023

Detailed composition

Substance Quantity Type Category
I
500.0 MG Substance Wirkstoff (Principe actif)
II
10.0 MG Substance Wirkstoff (Principe actif)
I
- Substance HNIDK
II
20.0 MG Substance HBESI
II
100.0 MG Substance HBESI
I
- Substance HNIDK
II
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance HNIDK
II
- Substance HNIDK
I
- Substance FNIDK
I
- Substance FIMDK
I
- Substance FIMDK
I
- Substance HNIDK
I
- Substance HNIDK

Authorization holder

Bayer (Schweiz) AG

8045 Zürich

Authorization information

Swissmedic authorization number
68353
Drug name
Gyno-Canesten, Kombi FORTE
Galenic form
KAWVV
ATC Code
G01AF02
Authorization status
Z
Dispensing category
D
First authorization
15/12/2022
Authorization expiration date
14/12/2027
IT Number
09.03.0.
Domain
Human medicine
Field of application
Durch Clotrimazol-empfindliche Erreger verursachte vulvovaginale Infektionen

Package details

Description (FR)
GYNO-CANESTEN Combi FORTE caps vag & crème
Description (DE)
GYNO-CANESTEN Kombi FORTE Vaginalkaps & Creme
Market launch
15/12/2022
Narcotic (BTM)
No